XML 16 R43.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidating Financial Statements
6 Months Ended
Jun. 30, 2011
Consolidating Financial Statements  
Consolidating Financial Statements

16. Consolidating Financial Statements

        In accordance with the provisions of the Second Lien Senior Indenture, as wholly owned subsidiaries of UHS, Emergent Group and PRI Medical have jointly and severally guaranteed all the Company's Obligations (as defined in the Second Lien Senior Indenture) under the Second Lien Senior Indenture on a full and unconditional basis. Consolidating financial information of UHS and the guarantors is presented on the following pages.

Consolidating Balance Sheets
(in thousands, except share and per share information)
(unaudited)

 
  At June 30, 2011  
 
  Parent
Issuer
UHS
  Subsidiary
Guarantor
Emergent Group
  Consolidating
Adjustments
  Consolidated  

Assets

                         

Current assets:

                         
 

Cash and cash equivalents

  $ 35,914   $ 1,833   $   $ 37,747  
 

Accounts receivable, less allowance for doubtful accounts

    61,258     4,130         65,388  
 

Due from (to) affiliates

    (1,150 )   1,150          
 

Inventories

    4,770     1,261         6,031  
 

Deferred income taxes

    11,656     286         11,942  
 

Other current assets

    3,838     1,359         5,197  
                   
   

Total current assets

    116,286     10,019         126,305  

Property and equipment, net:

                         
 

Medical equipment, net

    224,646     7,162         231,808  
 

Property and office equipment, net

    21,882     191         22,073  
                   
   

Total property and equipment, net

    246,528     7,353         253,881  

Other long-term assets:

                         
 

Goodwill

    283,141     40,848         323,989  
 

Investment in subsidiary

    60,210         (60,210 )    
 

Other intangibles, net

    230,052     21,472         251,524  
 

Other, primarily deferred financing costs, net

    14,014     77         14,091  
                   
   

Total assets

  $ 950,231   $ 79,769   $ (60,210 ) $ 969,790  
                   

Liabilities and Total Equity

                         

Current liabilities:

                         
 

Current portion of long-term debt

  $ 3,767   $ 1,795   $   $ 5,562  
 

Interest rate swap

    11,019             11,019  
 

Book overdrafts

    4,739             4,739  
 

Accounts payable

    21,777     1,798         23,575  
 

Accrued compensation

    13,335     1,185         14,520  
 

Accrued interest

    4,827             4,827  
 

Dividend payable

    33,501             33,501  
 

Other accrued expenses

    12,603     752         13,355  
                   
   

Total current liabilities

    105,568     5,530         111,098  

Long-term debt, less current portion

   
647,706
   
2,428
   
   
650,134
 

Pension and other long-term liabilities

    6,756     1,466         8,222  

Payable to Parent

    16,937             16,937  

Deferred income taxes

    65,296     9,765         75,061  

Commitments and contingencies (Note 10)

                         

Total equity

                         
 

Common stock

                 
 

Additional paid-in capital

    214,294     60,019     (60,019 )   214,294  
 

Accumulated income (deficit)

    (95,022 )   191         (94,831 )
 

Accumulated earnings in subsidiary

    191         (191 )    
 

Accumulated other comprehensive loss

    (11,495 )           (11,495 )
                   
   

Total Universal Hospital Services, Inc. equity

    107,968     60,210     (60,210 )   107,968  
                   
   

Non controlling interest

        370         370  
   

Total equity

    107,968     60,580     (60,210 )   108,338  
                   
   

Total liabilities and equity

  $ 950,231   $ 79,769   $ (60,210 ) $ 969,790  
                   


Consolidating Statements of Operations
(in thousands)
(unaudited)

 
  For the three months ended June 30, 2011  
 
  Parent
Issuer
UHS
  Subsidiary
Guarantor
Emergent Group
  Consolidating
Adjustments
  Consolidated  

Revenue

                         

Medical equipment outsourcing

  $ 65,792   $ 8,055   $   $ 73,847  

Technical and professional services

    11,361             11,361  

Medical equipment sales and remarketing

    5,876             5,876  
                   
 

Total revenues

    83,029     8,055         91,084  

Cost of Sales

                         

Cost of medical equipment outsourcing

    24,264     4,202         28,466  

Cost of technical and professional services

    8,227     0         8,227  

Cost of medical equipment sales and remarketing

    4,600     0         4,600  

Medical equipment depreciation

    16,808     697         17,505  
                   
 

Total costs of medical equipment outsourcing, technical and professional services and medical equipment sales and remarketing

    53,899     4,899         58,798  
                   

Gross margin

    29,130     3,156         32,286  

Selling, general and administrative

   
25,018
   
2,093
   
   
27,111
 

Acquisition and integration expenses

    831     394         1,225  
                   
 

Operating income

    3,281     669         3,950  

Equity in earnings of subsidiary

   
329
   
   
(329

)
 
 

Interest expense

    12,659     86         12,745  
                   
 

Loss before income taxes and non controlling interest

    (9,049 )   583     (329 )   (8,795 )

Provision (benefit) for income taxes

   
(7,774

)
 
254
   
   
(7,520

)
                   
 

Consolidated net loss

    (1,275 )   329     (329 )   (1,275 )
 

Net income attributable to non controlling interest

    138     138     (138 )   138  
                   
 

Net loss attributable to Universal Hospital Services, Inc. 

  $ (1,413 ) $ 191   $ (191 ) $ (1,413 )
                   


Consolidating Statements of Operations
(in thousands)
(unaudited)

 
  For the six months ended June 30, 2011  
 
  Parent
Issuer
UHS
  Subsidiary
Guarantor
Emergent Group
  Consolidating
Adjustments
  Consolidated  

Revenue

                         

Medical equipment outsourcing

  $ 132,031   $ 8,055   $   $ 140,086  

Technical and professional services

    22,231             22,231  

Medical equipment sales and remarketing

    11,482             11,482  
                   
 

Total revenues

    165,744     8,055         173,799  

Cost of Sales

                         

Cost of medical equipment outsourcing

    48,698     4,202         52,900  

Cost of technical and professional services

    16,110             16,110  

Cost of medical equipment sales and remarketing

    8,900             8,900  

Medical equipment depreciation

    33,976     697         34,673  
                   
 

Total costs of medical equipment outsourcing, technical and professional services and medical equipment sales and remarketing

    107,684     4,899         112,583  
                   

Gross margin

    58,060     3,156         61,216  

Selling, general and administrative

   
47,398
   
2,093
   
   
49,491
 

Acquisition and integration expenses

    1,605     394         1,999  
                   
 

Operating income

    9,057     669         9,726  

Equity in earnings of subsidiary

   
329
   
   
(329

)
 
 

Interest expense

    24,364     86         24,450  
                   
 

Loss before income taxes and non controlling interest

    (14,978 )   583     (329 )   (14,724 )

Provision (benefit) for income taxes

   
(7,561

)
 
254
   
   
(7,307

)
                   
 

Consolidated net loss

    (7,417 )   329     (329 )   (7,417 )
 

Net income attributable to non controlling interest

    138     138     (138 )   138  
                   
 

Net loss attributable to Universal Hospital Services, Inc. 

  $ (7,555 ) $ 191   $ (191 ) $ (7,555 )
                   


Consolidating Statements of Cash Flows
(in thousands)
(unaudited)

 
  For the six months ended June 30, 2011  
 
  Parent
Issuer
UHS
  Subsidiary
Guarantor
Emergent Group
  Consolidating
Adjustments
  Consolidated  

Cash flows from operating activities:

                         
 

Consolidated net loss

  $ (7,746 ) $ 329   $   $ (7,417 )
 

Adjustments to reconcile net loss to net cash provided by operating activities:

                         
   

Depreciation

    38,677     737         39,414  
   

Amortization of intangibles, deferred financing costs and bond premium

    7,999     677         8,676  
   

Provision for doubtful accounts

    405     (5 )       400  
   

Provision for inventory obsolescence

    76             76  
   

Non-cash stock-based compensation expense

    2,196             2,196  
   

Non-cash gain on trade-in of recalled equipment

    (3,292 )           (3,292 )
   

Loss (gain) on sales and disposals of equipment

    (807 )   6         (801 )
   

Deferred income taxes

    (7,352 )   243         (7,109 )
 

Changes in operating assets and liabilities:

                         
   

Accounts receivable

    (1,702 )   392         (1,310 )
   

Due from (to) affiliates

    1,150     (1,150 )        
   

Inventories

    (85 )   (40 )       (125 )
   

Other operating assets

    (299 )   47         (252 )
   

Accounts payable

    (1,738 )   (373 )       (2,111 )
   

Other operating liabilities

    2,446     299         2,745  
                   
     

Net cash provided by operating activities

    29,928     1,162         31,090  
                   

Cash flows from investing activities:

                         
 

Medical equipment purchases

    (47,997 )   (119 )       (48,116 )
 

Property and office equipment purchases

    (3,227 )   (8 )       (3,235 )
 

Proceeds from disposition of property and equipment

    1,492     4         1,496  
 

Acquisitions, net of cash acquired

    (66,519 )       1,480     (65,039 )
                   
     

Net cash used in investing activities

    (116,251 )   (123 )   1,480     (114,894 )
                   

Cash flows from financing activities:

                         
 

Proceeds under senior secured credit facility

    132,250             132,250  
 

Payments under senior secured credit facility

    (185,150 )           (185,150 )
 

Payments of principal under capital lease obligations

    (2,175 )   (539 )       (2,714 )
 

Payment of deferred financing costs

    (3,500 )           (3,500 )
 

Proceeds from issuance of bonds

    178,938             178,938  
 

Accrued interest received from bondholders

    661             661  
 

Cash paid to non controlling interests

        (147 )       (147 )
 

Proceeds from exercise of parent company stock options

    40             40  
 

Change in book overdrafts

    1,173             1,173  
                   
     

Net cash provided by (used in) financing activities

    122,237     (686 )       121,551  
                   
   

Net change in cash and cash equivalents

    35,914     353     1,480     37,747  

Cash and cash equivalents at the beginning of period

   
   
1,480
   
(1,480

)
 
 
                   

Cash and cash equivalents at the end of period

  $ 35,914   $ 1,833   $   $ 37,747